Webinar title: Urine-based NGS liquid biopsy applications in bladder cancer Date: Tuesday, March 23, 2021 Duration: 40 minutes Speaker: Bonnie King, PhD, Associate Director of Translational Medicine, Predicine, Inc. Urine-based liquid biopsy is showing signs of great promise for profiling urothelial malignancies, which shed DNA directly into urine. Predicine and collaborators recently presented work at ASCO-GU 2021 demonstrating...
Predicine is Exhibiting at AACR 2024 from April 5-10 with 14 Posters Featured!